168 related articles for article (PubMed ID: 9201145)
1. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin.
Tarantino MD; Ross MP; Daniels TM; Nichols WL
J Pediatr Hematol Oncol; 1997; 19(3):226-31. PubMed ID: 9201145
[TBL] [Abstract][Full Text] [Related]
2. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V.
Bänninger H; Hardegger T; Tobler A; Barth A; Schüpbach P; Reinhart W; Lämmle B; Furlan M
Br J Haematol; 1993 Nov; 85(3):528-32. PubMed ID: 8136275
[TBL] [Abstract][Full Text] [Related]
3. Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency.
Cmolik BL; Spero JA; Magovern GJ; Clark RE
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):222-7; discussion 227-8. PubMed ID: 8429648
[TBL] [Abstract][Full Text] [Related]
4. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
Streiff MB; Ness PM
Transfusion; 2002 Jan; 42(1):18-26. PubMed ID: 11896308
[TBL] [Abstract][Full Text] [Related]
5. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin.
Zehnder JL; Leung LL
Blood; 1990 Nov; 76(10):2011-6. PubMed ID: 2242423
[TBL] [Abstract][Full Text] [Related]
6. Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure.
Savage WJ; Kickler TS; Takemoto CM
Pediatr Blood Cancer; 2007 Dec; 49(7):1025-9. PubMed ID: 16526049
[TBL] [Abstract][Full Text] [Related]
7. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
[TBL] [Abstract][Full Text] [Related]
8. Bovine thrombin-induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patients. Report of three cases.
Spero JA
J Neurosurg; 1993 May; 78(5):817-20. PubMed ID: 8468613
[TBL] [Abstract][Full Text] [Related]
9. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
Lo CY; Jones C; Glader B; Zehnder JL
Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
[TBL] [Abstract][Full Text] [Related]
10. Bovine thrombin induces an acquired coagulopathy in sensitized patients undergoing revision spinal surgery: a report of two cases.
Poynton AR; Nelson MC; McCance SE; Levine RL; O'Leary PF
Spine (Phila Pa 1976); 2003 Jun; 28(12):E221-3. PubMed ID: 12811284
[TBL] [Abstract][Full Text] [Related]
11. Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure.
Donohoe K; Levine R
J Thromb Haemost; 2015 Oct; 13(10):1787-9. PubMed ID: 26270511
[TBL] [Abstract][Full Text] [Related]
12. Transfusion management of factor V deficiency: three case reports and review of the literature.
Gavva C; Yates SG; Rambally S; Sarode R
Transfusion; 2016 Jul; 56(7):1745-9. PubMed ID: 27125565
[TBL] [Abstract][Full Text] [Related]
13. Acquired Factor V Deficiency Associated with CFPM Administration.
Yamanishi M; Nishimi Y; Usui M; Miki K; Imashuku S
Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625361
[TBL] [Abstract][Full Text] [Related]
14. Development of antibodies to bovine and human factor V in two children after exposure to topical bovine thrombin.
Israels SJ; Israels ED
Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):249-54. PubMed ID: 8037345
[TBL] [Abstract][Full Text] [Related]
15. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.
Berruyer M; Amiral J; Ffrench P; Belleville J; Bastien O; Clerc J; Kassir A; Estanove S; Dechavanne M
J Thorac Cardiovasc Surg; 1993 May; 105(5):892-7. PubMed ID: 8487567
[TBL] [Abstract][Full Text] [Related]
16. [A case positive for the inhibitor for coagulation factor V].
Nakagoshi R; Takamiya O; Nakata S; Ishikawa S; Higuchi Y; Okumura N; Ogiso Y
Rinsho Byori; 1999 Oct; 47(10):971-5. PubMed ID: 10590673
[TBL] [Abstract][Full Text] [Related]
17. Severe bleeding due to factor V inhibitor after repeated operations using fibrin sealant containing bovine thrombin.
Muntean W; Zenz W; Edlinger G; Beitzke A
Thromb Haemost; 1997 Jun; 77(6):1223. PubMed ID: 9241765
[No Abstract] [Full Text] [Related]
18. [Development of asymptomatic acquired factor V inhibitor after the administration of antibiotics].
Kinjo Y; Yoshimura K; Suzuki T; Shinozawa K; Nakasone K; Yoshimata T; Nishihira M; Henzan E
Rinsho Ketsueki; 2014 Nov; 55(11):2311-5. PubMed ID: 25501413
[TBL] [Abstract][Full Text] [Related]
19. Management of bleeding in severe factor V deficiency with a factor V inhibitor.
Ardillon L; Lefrançois A; Graveleau J; Fouassier M; Ternisien C; Sigaud M; Fretigny M; Archambeaud I; Trossaërt M
Vox Sang; 2014 Jul; 107(1):97-9. PubMed ID: 24517203
[TBL] [Abstract][Full Text] [Related]
20. "In vitro" correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate.
Bulato C; Novembrino C; Anzoletti MB; Spiezia L; Gavasso S; Berbenni C; Tagariello G; Farina C; Nardini I; Campello E; Peyvandi F; Simioni P
Haemophilia; 2018 Jul; 24(4):648-656. PubMed ID: 29578313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
